Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Conditions:   Poliomyelitis;   Tetanus;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Diphtheria;   Hepatitis BIntervention:   Biological: Infanrix hexa™Sponsor:   GlaxoSmithKlineCompleted - verified April 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials